| Serial Number | 79308794 |
| Word Mark | NAVINOVA |
| Filing Date | Monday, December 21, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 13, 2022 |
| Registration Number | 6841307 |
| Registration Date | Tuesday, September 13, 2022 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 28, 2022 |
| Description of Mark | The mark consists of the term "NAVINOVA" in stylized orange font. |
| Goods and Services | Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin |
| Indication of Colors claimed | The color(s) orange is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NAVIN FLUORINE INTERNATIONAL LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | IN |
| Party Name | NAVIN FLUORINE INTERNATIONAL LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | IN |
| Party Name | NAVIN FLUORINE INTERNATIONAL LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IN |
| Event Date | Event Description |
| Tuesday, January 3, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, December 14, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, December 14, 2022 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 13, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 13, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 13, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 28, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 8, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, May 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 18, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 18, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 18, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 18, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, May 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 13, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 13, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 27, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, January 27, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 11, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, December 21, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, December 9, 2021 | ASSIGNED TO LIE |
| Wednesday, December 8, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, December 6, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 6, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 6, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 19, 2021 | REFUSAL PROCESSED BY IB |
| Thursday, July 1, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 1, 2021 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 22, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, June 21, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 16, 2021 | ASSIGNED TO EXAMINER |
| Saturday, April 24, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, April 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, April 15, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |